Weighing a semaglutide care offer
Bring these cautions to the prescribing conversation.
A label is a medicine's official product information. Have the person providing your care explain how those cautions relate to your health history.
Ask about the thyroid finding and its limits
- Does my personal or family history affect this decision?
- What does the animal finding tell us, and what remains unknown?
Keep in mind The semaglutide (Ozempic, Wegovy) labels checked on September 26, 2026 carried a boxed warning, the strongest FDA label alert.
That warning concerns thyroid tumours, growths in a gland in the neck, seen in rats and mice.
The FDA is the US drug regulator; the labels say it is unknown whether semaglutide causes those tumours in people.
Under the labels, semaglutide cannot be used by someone whose own or family history includes medullary thyroid cancer, which is a rare cancer in the neck gland. The labels also exclude anyone with MEN 2, a rare condition that can be inherited within a family.
A prior serious allergy to semaglutide or its other ingredients also rules it out under the labels.
If you do not know the name of a family condition, bring any record you have. Ask the person treating you to check whether it is one of these conditions before deciding about medicine.
Discuss pregnancy plans and other medicines
- How do pregnancy plans affect the treatment decision?
- Are any of my current medicines in the same drug group?
Keep in mind For a planned pregnancy, the Wegovy label checked on September 26, 2026 directs prescribers to end treatment at least two months ahead.
That label advises against using Wegovy alongside another semaglutide product or another medicine in the same drug group. Bring your full medicine list and ask the doctor or pharmacist to mark any that belong to this group.
Tell the team about planned procedures
- How will the person prescribing the medicine and the team doing my procedure plan my care together?
Keep in mind Semaglutide makes food leave the stomach more slowly. Its label describes rare reports of food or fluid from the stomach entering the lungs during anesthesia or deep sedation.
Anesthesia can put someone to sleep for a procedure; deep sedation makes them very sleepy.
Before a procedure, patients are asked by the label to inform the team caring for them; it leaves unanswered whether stopping the medicine ahead of time reduces that problem.